Matches in SemOpenAlex for { <https://semopenalex.org/work/W2086291107> ?p ?o ?g. }
Showing items 1 to 75 of
75
with 100 items per page.
- W2086291107 abstract "Lupus nephritis (LN) is the major determinant of outcome in pediatric systemic lupus erythematosus (pSLE), and its treatment remains a challenge. The aim of this study was to report the experience of our center in treating with rituximab (RTX) SLE patients with severe LN. Four pSLE patients with biopsy-proven LN, who are refractory to conventional immunosuppressive treatment, received four doses of 375-500 mg/m(2) RTX, 2-3 weeks apart. All patients were concurrently receiving corticosteroids (CSs) and mycophenolate mofetil. Patients' clinical and laboratory findings were recorded at RTX initiation, after each infusion and at 3.4 ± 2.1 month intervals thereafter. pSLE activity was assessed using the European Consensus Lupus Activity Measurement (ECLAM), while LN activity using 24-hour urine protein excretion and serum cystatin C. Patients were followed up for 6-21 months (median: 16 months). Full Β-cell depletion was noticed 2-4 weeks after RTX initiation and lasted 4-7 months. All patients achieved complete LN remission 3.5 months (range: 2-4) after RTX initiation, which was retained in 3 patients through the follow-up period. One patient relapsed 15 months after RTX initiation and received one additional RTX dose. ECLAM scores and CSs doses were markedly reduced in all patients, while complement levels were increased. No side effects or infections were observed. In conclusion, RTX is an alternative, safe and efficient treatment for refractory LN." @default.
- W2086291107 created "2016-06-24" @default.
- W2086291107 creator A5014066654 @default.
- W2086291107 creator A5017854572 @default.
- W2086291107 creator A5034822821 @default.
- W2086291107 creator A5067072168 @default.
- W2086291107 creator A5071084542 @default.
- W2086291107 creator A5089398978 @default.
- W2086291107 date "2011-09-14" @default.
- W2086291107 modified "2023-09-26" @default.
- W2086291107 title "Safety and efficacy of rituximab in refractory pediatric Systemic Lupus Erythematosus nephritis: a single-center experience of northern Greece" @default.
- W2086291107 doi "https://doi.org/10.1186/1546-0096-9-s1-p246" @default.
- W2086291107 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3194609" @default.
- W2086291107 hasPublicationYear "2011" @default.
- W2086291107 type Work @default.
- W2086291107 sameAs 2086291107 @default.
- W2086291107 citedByCount "0" @default.
- W2086291107 crossrefType "journal-article" @default.
- W2086291107 hasAuthorship W2086291107A5014066654 @default.
- W2086291107 hasAuthorship W2086291107A5017854572 @default.
- W2086291107 hasAuthorship W2086291107A5034822821 @default.
- W2086291107 hasAuthorship W2086291107A5067072168 @default.
- W2086291107 hasAuthorship W2086291107A5071084542 @default.
- W2086291107 hasAuthorship W2086291107A5089398978 @default.
- W2086291107 hasBestOaLocation W20862911071 @default.
- W2086291107 hasConcept C121332964 @default.
- W2086291107 hasConcept C126322002 @default.
- W2086291107 hasConcept C142424586 @default.
- W2086291107 hasConcept C16005928 @default.
- W2086291107 hasConcept C187212893 @default.
- W2086291107 hasConcept C198451711 @default.
- W2086291107 hasConcept C203014093 @default.
- W2086291107 hasConcept C2777058396 @default.
- W2086291107 hasConcept C2779134260 @default.
- W2086291107 hasConcept C2779338263 @default.
- W2086291107 hasConcept C2779912601 @default.
- W2086291107 hasConcept C2780073493 @default.
- W2086291107 hasConcept C2780653079 @default.
- W2086291107 hasConcept C71924100 @default.
- W2086291107 hasConcept C87355193 @default.
- W2086291107 hasConceptScore W2086291107C121332964 @default.
- W2086291107 hasConceptScore W2086291107C126322002 @default.
- W2086291107 hasConceptScore W2086291107C142424586 @default.
- W2086291107 hasConceptScore W2086291107C16005928 @default.
- W2086291107 hasConceptScore W2086291107C187212893 @default.
- W2086291107 hasConceptScore W2086291107C198451711 @default.
- W2086291107 hasConceptScore W2086291107C203014093 @default.
- W2086291107 hasConceptScore W2086291107C2777058396 @default.
- W2086291107 hasConceptScore W2086291107C2779134260 @default.
- W2086291107 hasConceptScore W2086291107C2779338263 @default.
- W2086291107 hasConceptScore W2086291107C2779912601 @default.
- W2086291107 hasConceptScore W2086291107C2780073493 @default.
- W2086291107 hasConceptScore W2086291107C2780653079 @default.
- W2086291107 hasConceptScore W2086291107C71924100 @default.
- W2086291107 hasConceptScore W2086291107C87355193 @default.
- W2086291107 hasLocation W20862911071 @default.
- W2086291107 hasLocation W20862911072 @default.
- W2086291107 hasLocation W20862911073 @default.
- W2086291107 hasLocation W20862911074 @default.
- W2086291107 hasOpenAccess W2086291107 @default.
- W2086291107 hasPrimaryLocation W20862911071 @default.
- W2086291107 hasRelatedWork W2004428500 @default.
- W2086291107 hasRelatedWork W2026800023 @default.
- W2086291107 hasRelatedWork W2071623855 @default.
- W2086291107 hasRelatedWork W2077823650 @default.
- W2086291107 hasRelatedWork W2171961585 @default.
- W2086291107 hasRelatedWork W2410406522 @default.
- W2086291107 hasRelatedWork W2742564616 @default.
- W2086291107 hasRelatedWork W2952445313 @default.
- W2086291107 hasRelatedWork W4248195772 @default.
- W2086291107 hasRelatedWork W2183241841 @default.
- W2086291107 isParatext "false" @default.
- W2086291107 isRetracted "false" @default.
- W2086291107 magId "2086291107" @default.
- W2086291107 workType "article" @default.